Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Synchrotrons and industrial structural biology

Abstract

Pharmaceutical and chemical companies play an increasingly significant role in the use and development of synchrotron facilities for structural biology.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew J. Howard.

Additional information

Center for Synchrotron Radiation Research and Instrumentation, Biological, Chemical, and Physical Sciences Department, Illinois Institute of Technology, Chicago, IL 60616 USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howard, A. Synchrotrons and industrial structural biology. Nat Struct Mol Biol 5 (Suppl 8), 623–626 (1998). https://doi.org/10.1038/1316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1316

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing